The downgrade to Neutral suggests that JP Morgan sees limited upside potential for EQH, which could temper investor enthusiasm. However, the increase in the price target to $36 indicates a slight improvement in the valuation outlook. The mixed nature of this update may result in a neutral short-term impact on the stock price, as the market digests both the downgrade and the increased price target.